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In addition to acting as template for protein synthesis, mRNA often contains sensory 
sequence elements that regulate this process1,2. Here we report a novel mechanism that 
limits the number of complete protein molecules that can be synthesised from a single mRNA 
molecule of the human AMD1 gene encoding adenosylmethionine decarboxylase 1 
(AdoMetDC). A small proportion of ribosomes translating AMD1 mRNA stochastically read 
through the stop codon of the main coding region. These readthrough ribosomes then stall 
close to the next in-frame stop codon eventually forming a ribosome queue whose length is 
proportional to the number of AdoMetDC molecules that were synthesized from the same 
AMD1 mRNA. Once the entire spacer region between the two stop codons is filled with 
queuing ribosomes, the queue impinges upon the main AMD1 coding region halting its 
translation. Phylogenetic analysis suggests that this mechanism is highly conserved in 
vertebrates and existed in their common ancestor. We propose that this mechanism is used 
to count and limit the number of protein molecules that can be synthesized from a single 
mRNA template. It could serve to safeguard from dysregulated translation that may occur 
due to errors in transcription or mRNA damage. 
AdoMetDC catalyses the decarboxylation of S-adenosylmethionine (AdoMet or SAM) 
which provides an aminopropyl group to polyamines such as spermidine and spermine3. SAM is 
an important metabolite as it serves as a major donor of methyl groups in numerous reactions 
involving methylation of DNA, RNA, proteins and metabolites4-6. Thus, in addition to its 
essential role in polyamine synthesis, AdoMetDC may also influence methylation reactions by 
affecting SAM availability. AdoMetDC is critical for embryonic stem cell self-renewal and 
differentiation to the neural lineage7. Its dysregulation is linked to tumorigenesis8, and its 
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overexpression in rodent fibroblasts gives rise to aggressive transformants with extremely high 
invasive capacity in nude mice9. The synthesis of AdoMetDC is tightly controlled at the 
translational level allowing for quick adjustment in response to changes in polyamine 
concentrations. In vertebrates, control is dependent on translation of an upstream Open 
Reading Frame (uORF) encoding a micropeptide MAGDIS10. MAGDIS stalls ribosomes at the 
uORF stop codon and the duration of the ribosome arrest depends on the concentration of 
polyamines. At high concentrations, extended pausing of ribosomes at the MAGDIS uORF 
inhibits translation initiation at the downstream ORF encoding AdoMetDC. At lower 
concentrations, ribosomes terminate at the uORF stop codon and can then efficiently reinitiate 
translation at the AdoMetDC ORF. This mechanism provides a simple negative feedback control 
loop for AdoMetDC autoregulation10.  
Analysis of publicly available ribosome profiling data11 not only confirms translation of 
the MAGDIS uORF but also reveals that it has the highest density of ribosome protected 
fragments within the AMD1 mRNA (Fig. 1a). However, the ribosome density profile of the 
AMD1 mRNA also revealed an unexpected feature: a strong isolated peak of ribosome footprint 
density in its 3’ trailer (a.k.a. 3’ UTR), 384 nucleotides downstream of the AMD1 stop codon 
(Fig. 1a). In general, prominent isolated peaks of ribosome footprint density are indicative of an 
extended translational pause but could instead result from mRNA protection not related to 
genuine translation, e.g. within a nucleoprotein complex with similar sedimentation properties 
to that of ribosomes. The latter was recently proposed as an explanation for the peak in the 
AMD1 3’ trailer12. The former could potentially occur if ribosomes read through the stop codon 
of the annotated AMD1 coding region (CDS) and then stall downstream. Occurrences of 
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efficient stop codon readthrough have been observed in the decoding of many viruses, but also 
in cellular genes of many organisms, including humans13-15. There are no in-frame stop codons 
downstream of the AMD1 stop until the peak of high density that occurs at the next in-frame 
stop codon. Thus, stop codon readthrough is a plausible explanation for the observed ribosome 
density peak.   
Evidence supportive of functionally significant stop codon readthrough was obtained by 
phylogenetic analysis of the downstream ORF which we will refer to hereafter as the AMD1 tail 
and its product as the AdoMetDC extension. We initially examined a UCSC 100 species genomic 
alignment16 with CodAlignView (Extended Data Fig. 1). The AMD1 tail ORF appeared to be 
conserved in the genomic sequence from ~80 tetrapods with a small variation in the naked 
mole rat. Given the low quality of some genomic sequences we expanded our analysis to all 
available vertebrate genomes and applied filtering to improve the quality (see Methods). This 
produced an alignment of 146-species (Extended Data Fig. 2). The origin of the AMD1 tail dates 
back to at least the root of vertebrates although it has been lost in a small group of amphibious 
fish species. The level of nucleotide conservation in the AMD1 tail is similar to that of the AMD1 
main ORF, peaking towards the middle. Analysis of the Ka/Ks ratio revealed weak purifying 
selection acting on amino acids encoded by the AMD1 tail which is strongest towards the end 
(last ~20 amino acids – see Fig. 1b). 
Examination of all available vertebrate ribosome profiling data in GWIPS-viz browser11 
confirmed the existence of a ribosome density peak at the 3’ end of the AMD1 tail in mouse, 
rat, frog and fish (Extended Data Fig. 3), strongly suggesting evolutionary conservation of, not 
only the tail ORF, but also of the potential ribosome stalling at its 3’ end. The AMD1 tail 
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ribosome density peak is also present in ribosome profiling data obtained from cells treated 
with drugs that preferentially block ribosomes at sites of translation initiation17,18. This is 
characteristic of stalling sites and a similar ribosome peak can be observed for the well 
characterized stalling site at the end of the XBP1 coding region19 (Extended Data Fig. 4).  
To determine whether the observed AMD1 tail peak indeed occurs as a result of 
ribosome arrest or because of protection by an RNA binding protein as suggested earlier12, we 
tested for ribosome stalling by monitoring the formation of stable peptidyl-tRNA complexes20 
during translation of full length and truncated AMD1 tails (Fig. 1c). Translation of AMD1 tails 
resulted in the formation of RNase-sensitive complexes that depended upon the 63 nucleotides 
immediately 5’ of the AMD1 tail stop, although the stop codon itself is not essential (Fig. 1c). 
Therefore, translation is stalled in a sequence-specific but stop codon-independent manner at 
the 3’ end of the AMD1 tail ORF. 
In an attempt to verify AMD1 stop codon readthrough and concomitant translation of 
the AMD1 tail, we designed a construct where a HA-tag was fused to the AdoMetDC N-
terminus (Fig. 2a). Stop codon readthrough would be expected to yield an additional product, 
longer by 128 residues. No readthrough product was detected by Western blotting using HA-tag 
antibodies (Fig. 2a). Surprisingly, however, we observed an almost complete loss of product in 
the positive control where the AMD1 stop codon was replaced with a sense codon (UGG 
construct). These observations suggest that translation of the AMD1 tail leads to a dramatic 
decrease in the corresponding protein product levels. To investigate this further and to 
quantitatively characterise this observation, the AMD1 tail was cloned into a dual luciferase 
vector downstream of, and in-frame with, sequence encoding Renilla luciferase (R Luc). 
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Translation of downstream internal control Firefly luciferease (F Luc) is initiated at an 
introduced EMCV internal ribosome entry site (IRES) (Fig. 2b) allowing monitoring of both 
luciferase activities from the same mRNA. We observe a massive, about 65-fold, reduction in 
relative R Luc activity in those constructs where the UGA stop codon was replaced by a UGG 
codon (Fig. 2b). IRES-driven F Luc activity is similar from both constructs, arguing against the 
possibility that tail translation and ribosome stalling affect mRNA stability (Extended Data Fig. 
5). However, to further rule out this possibility we performed RT-qPCR of the corresponding 
constructs and do not observe significant changes that could explain the large reduction in UGG 
construct product (Fig. 2b and Extended Data Fig. 5) 
The reduction of protein levels when the AMD1 tail is translated could be explained by 
the effect of the extension on AdoMetDC stability, localization or by inhibition of its translation. 
Indeed, protein destabilization via readthrough extension has been reported earlier for the 
yeast PDE2 mRNA21 and was recently proposed to be a general phenomenon22. To explore the 
effect of the extension on protein stability we designed additional constructs in which the 
AdoMetDC extension is fused to the C-terminus of GFP (Fig. 2c). Live cell confocal imaging and 
Western blotting analyses demonstrated a dramatic decrease in GFP levels in cells transfected 
with the UGG construct (Fig. 2d-f) that cannot be explained by the 2-fold reduction in RNA 
levels of the UGG mRNA (Fig. 2g).  The dramatic GFP reduction was also observed in constructs 
where UGA is replaced with sense codons other than UGG (Extended Data Fig. 6). The AMD1 
tail inhibitory effect is consistent across several reporter constructs suggesting that it is 
independent of the main AMD1 coding sequence.  
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Treatment of cells with the proteasome inhibitor MG132 did not restore the levels of 
GFP-UGG (Fig. 2d-f). Similarly, GFP-UGG levels remained low upon lysosome inhibition by 
dissipating their acidic pH with Concanamycin A (CMA) (Fig. 2h,i). Cell-free translation of the 
luciferase reporters in HEK293T lysates again resulted in significant reductions in R Luc levels 
from UGG mRNA compared to UGA mRNA, thus excluding the possibility that the inhibition is 
due to a non-canonical secretion signal in the AdoMetDC extension (Extended Data Fig. 7). 
Furthermore, we have excluded the possibility that the AMD1 tail effect may be a result of the 
AMD1 tail translation acting in trans (Extended Data Fig. 8) 
If the AdoMetDC extension does not affect protein stability and does not serve as a 
secretion signal, what could be responsible for the reduction in reporter expression? To explain 
our observations, we propose a model illustrated in Fig. 3a. Infrequent readthrough ribosomes 
encounter a strong stalling site close to the AMD1 tail stop codon and form a stable complex 
with the mRNA. Trailing ribosomes that also read through the AMD1 stop codon are stymied 
upstream of the stalling site and form a queue. The length of the queue is expected to be 
proportional to the number of AdoMetDC molecules produced from the same mRNA. Once the 
entire AMD1 tail is filled with queued ribosomes, all ribosomes translating AMD1 would be 
unable to finish synthesis of AdoMetDC unless the roadblock of queueing ribosomes is cleared. 
Such a mechanism could be used as a safeguard against dysregulated AMD1 mRNA molecules, 
e.g. those where, due to a synthesis error or damage, uORF mediated repression does not work 
properly. Translation of such dysregulated molecules would stop after a defined number of 
AdoMetDC molecules had been synthesized (Fig. 3a).  
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To test this hypothesis, we first took advantage of the StopGo peptide motif (a.k.a. Stop-
CarryOn or 2A) which effectively results in the skipping of a peptide bond by causing release of 
a nascent peptide in the absence of a stop codon and then continued translation23,24. We fused 
StopGo sequences to the 3’ end of R Luc sequences before the stop codon (or sense codon 
control) and the AMD1 tail (Fig. 3b). Therefore, the amino acid sequences of R Luc reporters 
produced from these constructs are identical irrespective of whether the AMD1 tail is 
translated. Despite this, we consistently observed a 3-fold reduction in relative R Luc activity in 
the construct where the wild type UGA codon was substituted with UGG (Fig. 3b). Western 
blotting analysis of R Luc and F Luc confirmed that the luciferase products from both constructs 
have identical sizes (Extended Data Fig. 9). This reduction in R Luc levels cannot be explained by 
an effect of the AdoMetDC extension on protein product properties (due to the presence of 
StopGo) or by mRNA stability, since the levels of IRES-driven F Luc observed with the UGA and 
UGG constructs are comparable (also confirmed by RT-qPCR, Extended Data Fig. 9c). The lower 
reduction in relative R Luc activities with (Fig. 3b) or without StopGo (Fig. 2b) when UGA is 
substituted with UGG is likely because StopGo is a slow process and it may decelerate queue 
formation. We also can not completely rule out the partial involvement of an uncharacterized 
protein degradation pathway.  
According to our model, an increased readthrough efficiency should accelerate 
formation of the queue that results in reducing reporter expression. To test this, we measured 
the activity of R Luc in constructs containing the AMD1 tail with R Luc stop codons in contexts 
known to permit varying levels of readthrough14,29. To measure readthrough efficiencies of the 
different stop codon contexts, it was necessary to first eliminate the AMD1 tail effect by 
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removing the last 50 codons (Fig. 3c), which includes sequence essential for stalling (Fig. 1c). A 
readthrough efficiency of ~2.3% was observed for the wild type AMD1 context (Fig. 3c) which is 
consistent with the low footprint density observed in ribosome profiles on the AMD1 tail (Fig. 
1a). The readthrough levels observed at other contexts were ~5%, 9% and 13.5% (Fig. 3c). As 
predicted from the model in Fig. 3a, reductions in relative R Luc activity were much greater 
than what would be expected solely due to inactivation of readthrough products when the 
stalling site is present (Fig. 3d). 
The scheme shown could be a simplification of the real situation. Provided that the 
stalled ribosomes are released with a certain rate s, ribosomes would accumulate in the tail 
only if s < i/n, where i is the rate of initiation and 1/n is the probability of stop codon 
readthrough. In this case, the proposed mechanism would be predicted to block translation on 
only those mRNA molecules at which the synthesis of AdoMetDC exceeds a certain rate (i>s/n). 
Such regulation would be particularly effective in AMD1 mRNA since the AdoMetDC half-life is 
less than 1 h25 and its cellular concentration is largely determined by its synthesis. It is 
conceivable that similar mechanisms regulate expression of other genes where tight control is 
required. Indeed, we identify a number of genes with ribosome footprint peaks between the 
protein coding ORF stop and the next in-frame stop codon, see Extended Data File 3, which, 
intriguingly contains EEF1A2 (see Extended Data Fig. 10 for further details). The exact function 
of stalling following stop codon readthrough needs to be investigated in a case by case manner, 
as it may vary. Queueing at the end of yeast antizyme (oaz) ORF, for example, has been 
suggested to reduce the efficiency of programmed ribosomal frameshifting in a polyamine 
dependent manner26. However, as the formation of the long queues required for both 
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proposed models has not been observed directly, the possibility of alternative mechanisms 
responsible for long range coordination between stalled ribosomes and translation far 
upstream on the same mRNA cannot be excluded.  
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Figure 1 | Translation of phylogenetically conserved AMD1 tail results in ribosome stalling. a. 
A profile of ribosome footprint (riboseq) density from aggregated publicly available datasets in 
GWIPS-viz browser. Top plot shows all ribosome footprints aligned in the AMD1 locus of the 
hg19 reference sequence assembly of the human genome. Below it are magnifications of the 
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areas in the vicinity of the regulatory MAGDIS uORF (left) and downstream of the AMD1 stop 
codon (right). Exact number of footprints at the highest peak for each region is indicated in red. 
b. Alignment of AMD1 sequences in a set of representative species. Synonymous and non-
synonymous substitutions are shown in blue and red, respectively, and gaps are in grey. Ka/Ks 
ratios and sequence identities (see Methods) are shown at the bottom. c. Anti-Flag Western 
blotting of FLAG tag fusions with AMD1 tail and its mutants. Cytomegalovirus (CMV) gp48 
uORF2 was used as a positive control. Covalent complexes of peptidyl tRNA with nascent 
peptide can be seen on the gel for the samples untreated with RNase.  
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Figure 2 | AMD1 tail reduces expression independent of proteasomes or lysosomes 
pathways. a. Anti-HA immunoblots of protein lysates from HEK293T cells either mock-
transfected (M) or transfected with constructs expressing HA-AMD1-UGA, HA-AMD1-UGG or 
HA-AMD1-UAA as indicated. b. Analysis of AMD1 tail translation effect on expression of dual 
reporter constructs (top); luciferase activity (bottom left), mRNA stability (bottom right). n=12 
for the boxplots. c. GFP constructs used in (d-h). d. Images of live cells expressing GFP 
constructs treated or untreated with proteasome inhibitor MG132 (10 µM). e. Quantitative 
analysis of (d). f. Western blotting analysis of cells expressing GFP constructs, HIF-2α was used 
as a positive control for proteasome inhibition, NE stands for GFP expressed with no extension. 
g. RT-qPCR analysis of RNA levels for GFP constructs from (c). h. Images of live cells expressing 
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GFP constructs not treated or treated with the lysosome inhibitor Concanamycin A (CMA, 
1µM). Acidic compartments were stained with LysoTracker Red (LTR). i. Quantitative analysis of 
(h) n=15 for each boxplot. Scale bar is 20 µm. 
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Figure 3 | AMD1 tail modulates translation of an upstream reporter ORF. a. Memory 
formation mechanism. Ribosomes read through the stop codon with frequency 1/n and their 
progression is arrested at the stall site (stalled ribosomes are shown in red). The number of 
proteins synthesized from a single mRNA molecule is proportional to the number of ribosomes 
queued in the tail. Once the entire tail is filled with ribosomes (maximum N) translation of main 
ORF is impaired. This mechanism sets a limit on the number ((n-1)N on average) of AdoMetDC 
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molecules that can be synthesized from a single mRNA. Not drawn to scale. b. Analysis of AMD1 
tail translation effect on upstream reporter translation in dual luciferase reporters containing 
the StopGo motif. c. Readthrough efficiencies determined by dual luciferase assay after 
transfection of HEK293T cells with indicated constructs. Normalized (Renilla/Firefly) luciferase 
activities were calculated for each as a percentage of the normalized UGG in-frame control. All 
constructs contain the first 219 nts of the AMD1 tail. d. The effect of stop codon readthrough 
context on translation of the upstream reporter. Broken lines indicate R Luc activities that 
would be expected if the extended proteins were immediately degraded. All data points are 
indicated as boxplots with the same symbols used for technical replicates that belong to the 
same biological replicate. 
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METHODS 
Cloning  
 Oligonucleotides were synthesized by IDT, Belgium. Primer sequences are listed in 
Extended Data Table 1. The sequence of the AMD1 coding region and the part of the 3’ trailer 
encoding the tail was obtained as a gBlock from IDT and its sequence is provided in Extended 
Data File 1. The amplicons were generated by standard one or multiple PCR reactions. Plasmids 
used in this study include pEGFP-C1 (Clontech), pcDNA3-HA (Invitrogen), pDluc27,28 and 
pSDLuc29. pDluc was modified such that the second luciferase reporter (firefly) is expressed 
under the control of the EMCV IRES. For StopGo constructs, the StopGo sequence24 was 
inserted in place of the Renilla stop codon. For readthrough measurements pSGDluc29 was 
used. Construct sequences are provided in Extended Data File 1. All constructs were 
transformed in E. coli strain DH5-α and were verified by sequencing.  
 
Tissue culture and cell treatment 
Human Embryonic Kidney 293T cells (ATCC) were maintained as monolayer cultures, 
grown in DMEM (Sigma-Aldrich) supplemented with 10% FBS, 1mM L-glutamine and antibiotics 
at 37°C in an atmosphere of 5% CO2. For dual luciferase assay 4x106 HEK293T cells were plated 
on 10 cm tissue culture dishes. After 24 hours the cells were detached with trypsin, suspended 
in fresh media and transfected in triplicate with Lipofectamine 2000 reagent (Invitrogen), using 
the 1-day protocol in which suspended cells are added directly to the DNA complexes in 96-well 
plates. For each transfection the following was added to each well: 50 ng plasmid DNA, 0.4 μl 
lipofectamine 2000 in 50 μl OptiMem (Gibco). 8x104 cells in 150 μl DMEM, were added to the 
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transfecting DNA complexes in each well. Transfected cells were incubated at 37°C in 5% CO2 
for 21 h and assayed using the dual luciferase assay.  
Transfections for Western blotting of EGFP encoding constructs for Extended Data Fig. 6 
and for HA-AMD1 and RT-qPCR analysis were performed in 6 well plates scaled-up from the 
method described for 96 well plate transfections above. The following was added to each well: 
1ug plasmid DNA, 7μl lipofectamine 2000 in 1 ml OptiMem. 1x106 cells in 3 ml DMEM, were 
added to the transfecting DNA complexes in each well. Transfected cells were incubated at 37° 
C in 5% CO2 for 36 h for Western blotting and 21 h followed by RNA extraction for RT-qPCR.  
For Western blotting analysis of plasmids encoding EGFP (Fig. 2f), cells were seeded at 
1×106 cells per well on 12-well plates and grown for 16 h before transfection. For confocal 
fluorescence microscopy, cells were seeded at 2×104 on MatTek glass bottom dishes pre-coated 
with collagen IV / poly-D-lysine. Loading of the cells with fluorescent indicator LysoTracker Red 
DND-99 (Invitrogen) (100 nM) was performed in OptiMEM medium for 30 min. in CO2 
incubator. For proteasome inhibition, 10µM MG132 (Sigma-Aldrich) was added to transfected 
cells for 5 h prior to microscopy imaging or cell lysis and Western blotting analysis. 
Concanamycin A (Sigma-Aldrich) treatment (1µM) was performed for 5 h prior to microscopy 
imaging.  
 
Confocal microscopy 
Live cell imaging was conducted on an Olympus FV1000 confocal laser scanning 
microscope with controlled CO2, humidity and temperature. EGFP was excited at 488 nm (2.5-
10% of laser power) with emission collected at 500-540 nm. LysoTracker Red was excited at 543 
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nm (15% of laser power); emission was collected at 560-600 nm. Acquisition of each spectral 
signal was done in sequential laser mode. Fluorescence and differential interference contrast 
(DIC) images were collected with a 60X oil immersion objective in 12 planes using 0.5 µm steps. 
The resulting single images were analysed using FV1000 Viewer (Olympus), Adobe Photoshop 
and Illustrator software.  
 
Protein Isolation and Western Blot Analysis 
For Western blotting analysis of plasmids encoding EGFP for Fig. 2f, whole cell lysates 
were prepared in a standard RIPA buffer (Thermo Fisher) containing protease and phosphatase 
inhibitors. After lysate clarification, protein concentration was measured using BCATM Protein 
Assay kit (Thermo Fisher) and equalised. Proteins were separated by 4-20% polyacrylamide gel 
electrophoresis on pre-made acrylamide gels (GenScript), transferred onto a 0.2 μm 
ImmobilonTM-P PVDF membrane (Sigma-Aldrich) using wet mini-transfer system Hoefer™ TE 22 
(Hoefer) and probed with antibodies against HIF-2α (R&D systems), α-tubulin (Sigma-Aldrich) 
and GFP (Novex) in 5% fat-free milk in TBST (0.8% Tween-20) overnight at 4°C (primary) and for 
2 h at room temperature (secondary). Immunoblots were analysed with HRP-conjugated 
secondary antibodies (Sigma-Aldrich) and Amersham™ ECL™ Prime reagents using the LAS-3000 
Imager (Fujifilm) and Image Reader LAS-3000 2.2 software. Quantitative analysis was conducted 
using ImageJ program. 
For EGFP encoding plasmids for Extended Data Fig 6, HA and luciferase encoding 
plasmids, cells were washed with 1x PBS and lysed in 1x PLB (Passive Lysis Buffer, Promega). 
Proteins were separated by 4-12% polyacrylamide gel electrophoresis on pre-made BoltTM 4-
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12% BisTris Plus gels (Thermo Fisher), transferred onto nitrocellulose membranes (Protran) and 
incubated with primary antibodies in 5% fat-free milk in PBST (1% Tween-20) overnight at 4°C. 
Primary antibodies were against HA (clone 16B12: Covance), Renilla (MBL), firefly (Promega) 
and GFP (Santa Cruz). Incubation with fluorescently labelled secondary antibodies was for 0.5 h 
at room temperature.  
 
Dual luciferase assay 
Firefly and Renilla luciferase assay buffers were prepared as described in Dyer et al30. 
Relative light units were measured on a Veritas Microplate Luminometer fitted with two 
injectors (Turner Biosystems). Cells transfected in 96 well plate were washed once with 1× PBS 
and then lysed in 18 μl of 1× passive lysis buffer (PLB; Promega), and light emission was 
measured following injection of 50μl of each luciferase substrate buffer.  
 
RNA extraction and qPCR  
For cells transfected with dual luciferase constructs, RNA was extracted using TRIzol 
Reagent® (Ambion) according to manufacturer’s protocol followed by precipitation with 
isopropanol. 200 ng RNA were DNase treated (RQ1-DNase, Promega) and reverse transcribed with 
oligo dT-Primer and Superscript III (Thermo Fischer). Quantitative Real-time PCR (qRT-PCR) was 
performed in 10μl Reactions using the QuantiFast SYBR Green (Qiagen). The primers used are listed 
in the table S1. RNA levels of test constructs were normalised to beta-Actin mRNA levels. 
For EGFP encoding constructs, cells were washed with 1 x PBS and lysed with 1 x PLB 
(Promega). RNA was extracted using the phenol-chlorophorm method and precipitated with 
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isopropanol. 1µg RNA was DNase treated (RQ1-DNase, Promega). 200ng RNA were reverse 
transcribed with random oligo (IDT) and Superscript III (Thermo Fischer) in 20µl reactions 
according to the manufacturer’s recommendations. Quantitative Real-time PCR (qRT-PCR) was 
performed in 10µl reactions using the QuantiFast SYBR Green (Qiagen). The primers used are 
listed in the Extended Data Table 1. RNA levels of test constructs were normalised to the levels 
of the co-transfected control construct. The experiments were performed in two or three 
biological replicas each with two or three technical replicas at the stage of the RT-qPCR reaction. 
The fold difference was calculated by the Comparative CT Method (ΔΔCT Method)31. All data 
points were plotted.   
 
In vitro transcription  
mRNA for in vitro translation was produced with T7 RiboMAX™ Express Large Scale RNA 
Production System (Promega) following the manufacturer’s instructions with a PCR product 
serving as a template (primers used to generate the PCR templates are listed in extended data 
table 1). For translation in HEK293T cell free system mRNA was capped using the Vaccinia 
Capping System (NEB). For translation in RRL mRNA was not capped.   
 
In vitro translation in HEK293T cell free system 
HEK293T cell-free translation system was prepared as described in Terenin et al32. 
Briefly, HEK293T cells at ~ 75% of confluence were quickly harvested on ice and resuspended in 
Lysolecitin lysis buffer (20 mM HEPES-KOH pH 7.4, 100 mM KOAc ,2.2 mM Mg(OAc)2, 2 mM DTT, 
0.1mg/ml Lysolecitin). The cells were then spun down and resuspended in Hypotonic extraction 
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buffer (20mM HEPES pH 7.5, 10mM KOAc, 1mM Mg(OAc)2, 4mM DTT, Complete Protease 
Inhibitor Cocktail (EDTA-free; Roche)). The cells were then disrupted in a pre-cooled 2ml Dounce 
homogenizer. The lysates were collected following centrifugation for 10 min. at 10000 g. 10µl in 
vitro translation reactions were assembled in the presence of 50% v/v HEK293T cell-free lysate, 
1 x translation buffer (20mM Hepes–KOH pH 7.5, 1mM DTT, 0.5mM spermidine–HCl, 0.6mM Mg 
(OAc)2, 8mM creatine phosphate, 1mM ATP, 0.2mM GTP, 120mM KOAc and 25μM of each 
amino acid) and 200ng capped mRNA, as described in Andreev et al33.  
 
In vitro translation in RRL 
 RNA was translated in 10µl in vitro reactions using Flexi® Rabbit Reticulocyte Lysate 
System (Promega) according to the manufacturer’s recommendations. 
 
Monitoring of peptidyl-tRNA complexes  
 Translation reactions in RRL were carried out at 30° C for 1 h and then placed on ice. 
Half of the reaction (5µl) was then subjected to RNaseA treatment for 20 min. on ice. 2.5µl of 
RNase treated and 2µl of untreated samples were combined with 2 x Sample buffer 
supplemented with RNase inhibitor and loaded onto NuPage Bis-Tris neutral Gels (Thermo 
Fisher). The neutral pH prevents hydrolysis of peptidyl-tRNA bond. The products were detected 
with an ANTI-FLAG antibody (F1804, Sigma). The sequence of the human cytomegalovirus 
(CMV) gp48 uORF2 was used as a positive control for co-translational ribosome stalling34,35.  
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Gene finding and evolutionary analysis 
All publicly available genome sequences of vertebrates were downloaded from NCBI. We 
then used Selenoprofiles36 to identify AMD1 orthologs using a manually curated protein profile 
alignment that spans the main ORF. Gene structures were completed by extending homologous 
coding regions to the upstream methionine and first in-frame downstream stop. Results were 
filtered to exclude retrotransposed pseudogenes, abundant in mammals and recognizable for 
their lack of introns. The predictions were further filtered through manual inspection to obtain a 
bona fide set of 146 complete gene sequences across vertebrates with clear orthology. These 
gene structures were then extended by 120 nt upstream and 510 nt downstream, in order to 
include a similar length of non-coding sequence at each side (considering the AMD1 tail 
downstream of AMD1 main ORF stop). The phylogenetic tree of the investigated species was 
extracted from NCBI taxonomy37 and standardized arbitrarily to a dichotomic tree with ETE 338. 
Evolutionary analysis was then performed on the resulting alignment and tree using pycodeml, 
available at https://github.com/marco-mariotti/pycodeml. The rate of nonsynonymous vs 
synonymous substitutions (Ka/Ks) was computed with codeml39 using a fixed rate. This metric 
was computed in sliding windows throughout the alignment, each 30 codons wide and with a 3 
codon step. Sequence identity at nucleotide and protein level was also computed on the same 
alignment in sliding windows, each 3 codons wide and with a 3 codon step.  
Codon alignments for Extended Data Figs. 1 and 10b were produced using CodAlignView 
("CodAlignView: a tool for visualizing protein-coding constraint", I Jungreis, M Lin, M Kellis, in 
preparation.) 
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Identification of transcripts with ribosome footprint density profiles similar to AMD1 mRNA 
For each protein coding transcript in the Gencode v. 2240, the genomic coordinates of the 
region between the annotated CDS stop and the next in frame stop were extracted. Any 
nucleotide position within this region which overlapped with another annotated coding region 
in the Gencode annotations was discarded. The number of footprints at each remaining 
position was extracted from the global aggregate track of ribosome profiling data (hg38 
assembly and hg18 assembly with coordinates lifted over) in GWIPS-viz11. The positions with 
the highest number of footprints were recorded for each transcript. Any transcript with less 
than 500 footprints was discarded.  
 
Code availability 
All custom computer codes used in this study are available upon request. 
 
Data availability 
All data generated during this study are included in this published article (and its 
supplementary information files). In addition, publicly available data have been analysed in this 
study. Alignments of ribosome profiling data were obtained through GWIPS-viz 
(http://gwips.ucc.ie), genomic sequences have been obtained through GenBank and all relevant 
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sequences are provided in supplementary files. 
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EXTENDED DATA 
Note: Extended Data Figures 3-10 are available below, all other Extended Data items are 
submitted in separate files. 
Extended Data File 1 | Sequences of vectors and plasmids used in this study in fasta format. 
Extended Data File 2 | Genomic sequences of AMD1 coding regions and surrounding areas in 
fasta format.  
Extended Data File 3 | List of GENCODE transcripts containing peaks of ribosome density 
downstream and in-frame of protein coding regions. 
Extended Table 1. Sequences of DNA primers used in this study. 
Figure Legends 
Extended Data Figure 1 | Genomic alignment of tetrapods from UCSC Genome browser 100 
species alignment. Codon alignment was obtained with CodAlignView, positions of AMD1 stop 
and AMD1 tail stop are annotated (second row).  
Extended Data Figure 2| Alignment of AMD1 coding region and surrounding areas from 146 
vertebrate species. Synonymous and nonsynonymous substitutions are indicated by blue and 
red colours, respectively, and gaps are in grey. Ka/Ks ratio and sequence identity (see Methods) 
are shown at the bottom.  
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a. Mus musculus
 
b. Rattus norvegicus
 
c. Xenopus laevis 
 
d. Danio rerio 
 
Extended Data Figure 3 | Cross-species examination of AMD1 tail using publicly available 
ribosome profiling data in GWIPS-viz browser. Available ribosome footprints aligned to the 
genomes of (a) mouse, (b) rat, (c) frog and (d) fish are shown along with gene annotation tracks 
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and ORF plots in which ATG codons are shown in green and stop codons are shown in red. Note 
that even under very low coverage, peaks of density are consistently present at the stop codon 
of AMD1 tail. 
 
 
 
Extended Data Figure 4 | Human ribosome profiling data obtained with approaches that 
enrich ribosomes at the translation initiation sites. (a) AMD1 locus, (b) XBP1 locus. Three 
tracks are shown as indicated in the figure. Riboseq density corresponds to aggregated data 
obtained with drug treatments that preferentially arrest initiating ribosomes. Under these 
treatments actively elongating ribosomes run off. However, stalled ribosomes remain bound to 
mRNA and produce footprints along with initiating ribosomes blocked by these inhibitors. The 
peaks corresponding to ribosome stalling at the end of AMD1 tail and at the end of XBP1 coding 
region (in unprocessed mRNA) are indicated with arrows.  
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Extended Data Figure 5 | Assessment of dual luciferase mRNA stability. a. Scheme of 
constructs. b. RT-qPCR analysis with primers targeting R Luc sequence. c. Absolute values of R 
Luc and F Luc. Technical replicates that belong to the same biological replicate are indicated 
with the same symbols in panels b and c.  
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Extended Data Figure 6 | Expression of GFP constructs. Western blotting analysis of GFP 
fusions with a fragment of the actin 3’ trailer of the same length as AMD1 tail (full length, top) 
and truncated from the 5’ end tail, separated with stop and sense codons (bottom).  
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Extended Data Figure 7 | In vitro translation of AMD1 tail fusion reporters. Western blotting 
analysis of luciferase expressing mRNAs in HEK293T cell free translation system.  
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Extended Data Figure 8 | Potential trans effect of AMD1 tail translation. HEK293T cells were 
transfected in triplicate half-area 96 well plates with the indicated expression constructs (left) 
for 24 h. Cells were lysed in 15 μl PLB and incubated shaking for 15 min. at room temperature. 5 
μl of each was removed for immunoblotting with both anti-GFP and anti-β-Actin (upper right) 
and the remaining lysate assayed for both R Luc and F Luc activities (lower right), n=3. 
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Extended Data Figure 9 | Expression of StopGo constructs. a. Scheme of constructs. b. 
Western blots with antibodies against Renilla and Firefly. c. RT-qPCR analysis. 
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a.  
 
 
 
 
b. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Extended Data Figure 10 | EEF1A2 readthrough extension. a. GWIPS-viz screenshot of 
ribosome footprint density at the last 3’ exon of EEF1A2 (hg38). b. Multiple sequence alignment 
of 100 vertebrate genomes visualized with CodAlignView. It can be seen that the most 
conserved regions (no substitutions, white) coincides with the region upstream of the 
candidate stalling site. 
